Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Novoship reported for 9 months of 2024 by RAS

10/31/24 NOMP

Roman Avdeev sold a stake in Rossium to Sergey Sudarikov

10/31/24 CBOM

Board of Directors of IMCB recommended dividends

10/31/24 GEMA

Ozon Pharmaceuticals reported for 9 months of 2024 by RAS

10/31/24 OZPH

X5 Group opened its 700th OKOLO store

10/31/24 X5

Ozon launched a logistics complex in Yaroslavl

10/31/24 OZON

Pyatyorochka opened in Buryatia

10/31/24 X5

Fix Price may offer to exchange receipts for shares in the operating company

10/31/24 FIXP

Fix Price reported for 9 months of 2024

10/31/24 FIXP

Fix Price's LFL sales grew 1.2% in 9 months

10/31/24 FIXP